Physicians Briefing

  • 2015 MOC Program Expected to Cost $5.7 Billion Over 10 Years
    The 2015 version of the American Board of Internal Medicine maintenance-of-certification program is expected to generate considerable costs, mainly due to physician time costs, according to research published online July 28 in the Annals of Internal Medicine.
  • Autism Spectrum Disorder Care Costs Could Top $500B by 2025
    The annual cost of caring for Americans with autism spectrum disorder might reach $500 billion by 2025, with outside estimates approaching $1 trillion, according to a study published online July 17 in the Journal of Autism and Developmental Disorders.
  • Doctors Perform First Double Hand Transplant in a Child
    A young Baltimore boy has two new transplanted hands to replace ones he lost to amputation five years ago, his doctors announced Tuesday.
  • Early Invasive Strategy No Benefit 10 Years After NSTE-ACS
    For patients with non-ST-segment elevation acute coronary syndrome, routine early invasive strategy (coronary arteriography and myocardial revascularization, as clinically indicated) is not associated with improved outcomes at 10 years over a selective invasive strategy (coronary arteriography for recurrent ischemia only). The findings were published in the Aug. 4 issue of the Journal of the American College of Cardiology.
  • Early Surgery Tied to Increased Mortality in Polytraumatized
    For polytraumatized patients, surgery for thoracic spine trauma within 72 hours of trauma is associated with increased mortality, according to a study published in the Aug. 1 issue of The Spine Journal.
  • FDA Approves Balloon Device to Treat Obesity
    The ReShape Integrated Dual Balloon System has been approved by the U.S. Food and Drug Administration to combat adult obesity. Inflated inside the stomach, the device appears to create a sense of fullness, although how it works isn't completely understood, the FDA said in a news release.
  • Low Incidence of Diabetic Ketoacidosis With Canagliflozin
    For canagliflozin-treated patients with type 2 diabetes, the incidence of serious adverse events of diabetic ketoacidosis is low, according to research published online July 22 in Diabetes Care.
  • New Rx for Myeloid Malignancies Moves to Phase II Clinical Trials
    The selective Hedgehog antagonist PF-04449913 seems safe and is tolerated in adults with myeloid malignancies, according to a study published online July 26 in The Lancet Haematology.
  • No Significant Pregnancy Risks for Topical Retinoid Exposure
    Topical retinoid exposure is not significantly associated with an increased risk of major congenital malformations, spontaneous abortion, low birth weight, or prematurity, according to a review published online July 26 in the British Journal of Dermatology.
  • Novel Microendoscope Ups Accuracy of Esophageal Screening
    A novel, low-cost, high-resolution microendoscope improves the accuracy of Lugol's chromoendoscopy for screening and surveillance of esophageal squamous cell neoplasia, according to a study published in the August issue of Gastroenterology.
  • Outcomes Equal for Continuous, Intermittent β-Lactams in Sepsis
    Continuous and intermittent administration of β-lactam antibiotics are similarly efficacious for patients with severe sepsis, according to a study published online July 22 in the American Journal of Respiratory and Critical Care Medicine.
  • Probiotic Supplements May Help Prevent Infantile Eczema
    Probiotic supplementation in pregnancy and early infancy can prevent infantile eczema, according to a review and meta-analysis published online July 21 in Allergy.

Show More Results